Washington Trust Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Washington Trust Advisors's RMD Position: Q3 2026 in Review
Washington Trust Advisors reduced its ResMed (RMD) stake by 0.21% in Q3 2026, selling an estimated $53.7K and leaving 115,499 shares worth $25.5M. The position accounts for 1.82% of the portfolio, ranked #15.
Washington Trust Advisors first reported a position in RMD in Q4 2021 and has held it in 20 quarters since. The position peaked at $35.5M in Q4 2021. 875 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Washington Trust Advisors held 115,499 shares of ResMed worth $25.5M as of Q3 2026.
- Washington Trust Advisors sold 246 ResMed shares in Q3 2026, an estimated $53.7K.
- ResMed made up 1.82% of Washington Trust Advisors's portfolio in Q3 2026, its #15 holding.
- Washington Trust Advisors first reported a position in ResMed in Q4 2021 and has held it in 20 quarters since.
- Washington Trust Advisors's ResMed position peaked at $35.5M in Q4 2021.
- 875 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Washington Trust Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.